Yichen Dr. Xu
Beijing, 100142, China
NCT Number: NCT04224298
Based on the theory of traditional Chinese Medicine, this study collects eye features of white eyes through the White Eye Imaging Health Care System under visible light and establishes a database of eye-eye features corresponding to the disease. The computer image analysis and artificial intelligence technology are used to visualize the eye. The features were extracted and classified, and the corresponding changes in the characteristics of the traditional Chinese medicine and the disease were analyzed statistically to establish an analytical model corresponding to the disease.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Beijing, 100142, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2.5 years
The test will use Artificial Intelligence technology to analyze and learn the features of white-eye eyes of healthy people and patients with malignant tumors, and establish a model of eye characteristics of malignant tumors.
Peking University Cancer Hospital & Institute
Other
Application of White Eye Imaging Health Care System on Diagnosis of Malignant Tumors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04585269
Cancer Patients, Neoplasms
Tampa, Florida, United States
View Trial DetailsNCT03320161
Behavior, Cancer Patients
Amiens, France
View Trial DetailsNCT03393260
Cancer Patients, Disease Attributes
Paris, France
View Trial DetailsNCT01742143
Cancer Patients, Neoplasms
Basking Ridge, New Jersey, United States
View Trial Details